<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Guha A</submitter><funding>NCATS NIH HHS</funding><funding>American Heart Association-American Stroke Association</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH</funding><pagination>300-312</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8914878</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(4)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>The national incidence, risk factors, and associated mortality of atrial fibrillation (AF) in breast cancer patients are unknown.&lt;h4>Methods and results&lt;/h4>Using the Surveillance, Epidemiology, and End Results-Medicare-linked database, we identified females, ≥66 years old, with a new primary diagnosis of breast cancer from 2007 through 2014. These patients were individually matched 1:1 to Medicare enrolees without cancer, and each pair was followed for 1 year to identify a primary outcome of AF. Cumulative incidence was calculated using competing risk survival statistics. Following this, identifying risk factors of AF among breast cancer patients was conducted using the adjusted Cox proportional hazards model. Finally, Kaplan-Meier methods and adjusted Cox proportional hazard</pubmed_abstract><journal>European heart journal</journal><pubmed_title>Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.</pubmed_title><pmcid>PMC8914878</pmcid><funding_grant_id>K12 CA133250</funding_grant_id><funding_grant_id>P30 CA016058</funding_grant_id><funding_grant_id>K12-CA133250</funding_grant_id><funding_grant_id>K23 HL155890</funding_grant_id><funding_grant_id>K24 HL148521</funding_grant_id><funding_grant_id>16EIA26410001</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>K23-HL155890</funding_grant_id><funding_grant_id>P30 CA014236</funding_grant_id><pubmed_authors>Guha A</pubmed_authors><pubmed_authors>Weintraub NL</pubmed_authors><pubmed_authors>Addison D</pubmed_authors><pubmed_authors>Fradley MG</pubmed_authors><pubmed_authors>Dent SF</pubmed_authors><pubmed_authors>Alonso A</pubmed_authors><pubmed_authors>Lustberg MB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.</name><description>&lt;h4>Aims&lt;/h4>The national incidence, risk factors, and associated mortality of atrial fibrillation (AF) in breast cancer patients are unknown.&lt;h4>Methods and results&lt;/h4>Using the Surveillance, Epidemiology, and End Results-Medicare-linked database, we identified females, ≥66 years old, with a new primary diagnosis of breast cancer from 2007 through 2014. These patients were individually matched 1:1 to Medicare enrolees without cancer, and each pair was followed for 1 year to identify a primary outcome of AF. Cumulative incidence was calculated using competing risk survival statistics. Following this, identifying risk factors of AF among breast cancer patients was conducted using the adjusted Cox proportional hazards model. Finally, Kaplan-Meier methods and adjusted Cox proportional hazard</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-05T12:31:53.194Z</modification><creation>2025-04-05T12:31:53.194Z</creation></dates><accession>S-EPMC8914878</accession><cross_references><pubmed>34791123</pubmed><doi>10.1093/eurheartj/ehab745</doi></cross_references></HashMap>